PMID- 29566588
OWN - NLM
STAT- MEDLINE
DCOM- 20200603
LR  - 20200603
IS  - 1464-0694 (Electronic)
IS  - 0960-2011 (Linking)
VI  - 30
IP  - 1
DP  - 2020 Jan
TI  - Effectiveness of ReSET; a strategic executive treatment for executive 
      dysfunctioning in patients with Parkinson's disease.
PG  - 67-84
LID - 10.1080/09602011.2018.1452761 [doi]
AB  - In this multicentre randomised controlled trial (RCT), 43 patients with 
      Parkinson's disease (PD) were randomly allocated to either the experimental 
      condition receiving cognitive rehabilitation including strategy training (ReSET; 
      Strategic Executive Treatment, n = 24) or to the control condition receiving 
      computerised repetitive practice training for attention (Cogniplus, n = 16). We 
      expected that strategy training (ReSET) would be more effective than cognitive 
      training (Cogniplus) in improving patients' everyday life executive functioning. 
      Neuropsychological assessment was administered at baseline, at 2 weeks and 3-5 
      months post-treatment. Primary outcome measure was the Role Resumption List 
      (RRL). Secondary outcome measures were treatment goal attainment (TGA), 
      Dysexecutive Questionnaire (DEX), Parkinson's Disease Questionnaire (PDQ-39), 
      Zarit Burden Interview (ZBI) and neuropsychological tests. No effects of 
      treatment were found on the primary outcome measure and on neuropsychological 
      tests, except for one test of attention. At 2 weeks and 3-5 months 
      post-treatment, PD patients in both the ReSET and Cogniplus group reported a 
      significant improvement in everyday life executive functioning, as measured with 
      TGA and the DEX-self, with an advantage for ReSET only shortly after treatment. 
      Given these results and that PD patients were able to adhere to these treatments 
      despite their motor symptoms and fatigue (i.e., the drop-out rate was small), we 
      conclude that both strategy training and cognitive training for impairments in EF 
      might be beneficial and feasible for PD patients.
FAU - Vlagsma, Thialda T
AU  - Vlagsma TT
AD  - Department of Clinical & Developmental Neuropsychology, University of Groningen, 
      Groningen, The Netherlands.
FAU - Duits, Annelien A
AU  - Duits AA
AD  - Department of Psychiatry and Psychology, Maastricht University Medical Center, 
      Maastricht, The Netherlands.
FAU - Dijkstra, Hilde T
AU  - Dijkstra HT
AD  - Department of Medical psychology, Medical Center Nij Smellinghe, Drachten, The 
      Netherlands.
FAU - van Laar, Teus
AU  - van Laar T
AD  - Department of Neurology, University Medical Center Groningen, Groningen, The 
      Netherlands.
FAU - Spikman, Jacoba M
AU  - Spikman JM
AD  - Department of Clinical & Developmental Neuropsychology, University of Groningen, 
      Groningen, The Netherlands.
AD  - Department of Neurology, University Medical Center Groningen, Groningen, The 
      Netherlands.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
DEP - 20180322
PL  - England
TA  - Neuropsychol Rehabil
JT  - Neuropsychological rehabilitation
JID - 9112672
SB  - IM
MH  - Adult
MH  - Aged
MH  - Attention
MH  - Cognition Disorders/*etiology/*rehabilitation
MH  - *Executive Function
MH  - Feasibility Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Neurological Rehabilitation
MH  - Neuropsychological Tests
MH  - Parkinson Disease/*psychology/*rehabilitation
MH  - Therapy, Computer-Assisted
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Executive impairments
OT  - Neuropsychological rehabilitation
OT  - Parkinson's disease
OT  - Strategy training
EDAT- 2018/03/24 06:00
MHDA- 2020/06/04 06:00
CRDT- 2018/03/24 06:00
PHST- 2018/03/24 06:00 [pubmed]
PHST- 2020/06/04 06:00 [medline]
PHST- 2018/03/24 06:00 [entrez]
AID - 10.1080/09602011.2018.1452761 [doi]
PST - ppublish
SO  - Neuropsychol Rehabil. 2020 Jan;30(1):67-84. doi: 10.1080/09602011.2018.1452761. 
      Epub 2018 Mar 22.